CM Hospitalar S/A (BVMF:VVEO3)

Brazil · Delayed Price · Currency is BRL

0.6300

-0.0200 (-3.08%)

Last updated: Aug 6, 2026, 4:25 PM GMT-3

CM Hospitalar S/A Financials Overview

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	11,614	11,567	11,583	11,084	8,747	6,219
Revenue Growth	1.74%	-0.14%	4.51%	26.72%	40.65%	40.91%
Gross Profit	1,731	1,669	1,306	1,735	1,397	1,097
Operating Income	566.11	528.89	-814.99	638.13	516.89	495.3
Net Income	20.17	18.24	-1,415	359.92	259.73	395.16
Earnings Per Share	0.06	0.06	-4.46	1.20	0.92	1.51
EPS Growth	-	-	-	31.05%	-39.41%	178.91%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Material	2,834	2,716	2,568
Medicine	8,664	8,732	8,920
Others	116.11	119.36	95.01
Total	11,614	11,567	11,583

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	532.83	658.56	1,130	1,001	2,016	2,204
Total Debt	3,875	3,871	4,195	3,418	3,480	2,264
Net Cash (Debt)	-3,342	-3,212	-3,065	-2,417	-1,464	-60.74
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-10.58	-10.17	-9.65	-8.05	-5.16	-0.23

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	335.06	276.58	34.15	-895.63	532.75	320.12
Capital Expenditures	-45.99	-45.49	-81.62	-168.1	-152.24	-77.95
Free Cash Flow	289.07	231.09	-47.47	-1,064	380.51	242.16
Free Cash Flow Growth	665.42%	-	-	-	57.13%	77.73%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	14.91%	14.43%	11.27%	15.65%	15.97%	17.64%
Operating Margin	4.87%	4.57%	-7.04%	5.76%	5.91%	7.96%
Pretax Margin	0.12%	0.39%	-13.74%	1.25%	2.38%	6.57%
Profit Margin	0.17%	0.16%	-12.22%	3.25%	2.97%	6.35%
FCF Margin	2.49%	2.00%	-0.41%	-9.60%	4.35%	3.89%

Dividends

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.137	0.277	0.405
Dividend Per Share Growth	-50.69%	-31.57%	-
Dividend Yield	1.01%	1.76%	2.27%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	10.18	24.59	-	12.41	17.60	13.66
Forward PE	14.24	13.46	18.64	10.04	11.57	14.38
P/FCF Ratio	0.71	1.94	-	-	12.01	22.30
PS Ratio	0.02	0.04	0.06	0.40	0.52	0.87